Alvaro Pereira has held the position of Chief Scientific Officer at Tools4Patient since its inception in 2013. Dr.Pereira holds a Ph.D. in Biochemistry from the University of Brussels. Dr. Pereira continued his academic research as a research fellow in the Bioorganic Chemistry and Neurophysiopathology departments at the same institution.

He began his industrial career at Eli Lilly and Company in the Clinical Pharmacology Department. Throughout his industrial career, he worked in clinical pharmacology with increasing responsibilities from individual Phase I studies through entire early-stage development programs (including proof of concept Phase IIa studies) for novel CNS agents. In 2007 he joined Aepodia, a consultancy clinical research organization where he ran the early-stage development section which comprised studies all studies from first-in-human through Phase IIb proof of concept including biomarker validation/development in a variety of different therapeutic areas.

Chantal Gossuin works as Chief Operating Officer at Tools4Patient since its inception in 2013. Ms. Gossuin holds a Master’s degree in Industrial Pharmacy from the University of Brussels. Ms. Gossuin began her industrial career in the Quality Control Department at Eli Lilly and Company, Fegersheim. Thereafter, she held positions with increasing responsibility at Lilly in the Clinical Trial Material Department where she was ultimately promoted to Team Leader. She then moved to UCB as Project Manager, Drug Product Management and Industrialization Department. In 2008 she became Clinical Project Leader at Aepodia, a consultancy clinical research organization.

Dominique Demolle serves as Chief Executive Officer of Tools4Patient since its inception in 2013. Dr. Demolle holds a Ph.D. in Biochemistry from the University of Brussels. She joined the Clinical Research Group of GD Searle and then Eli Lilly. She has held positions with increasing leadership responsibilities at Eli Lilly and Company with the Lilly Indianapolis Clinical Research Unit in the US and the European Operational Staff management and ultimately became the Associate Director of Global Early Phase Operations. In 2007 she co-founded and successfully developed a Consulting Clinical Research Organization including partnerships with pharma and biotech before she left to set up Tools4Patient with previous colleagues.